Open Access UCL Research: Impact of Being Eligible for Type 2 Diabetes Treatment on All-Cause Mortality and Cardiovascular Events: Regression Discontinuity Design Study https://t.co/gCsRYVWyE5
Our study applying the regression discontinuity design to over 43,000 Danish health records shows that being eligible for type 2 diabetes treatment was associated with 21% lower mortality and CVE. Reminder of the challenge of setting diagnostic thresholds
RT @i_petersen: Gosh my HbA1c is too high! We investigated the impact of being eligible for Type 2 Diabetes treatment on All-Cause Morta…
RT @i_petersen: Gosh my HbA1c is too high! We investigated the impact of being eligible for Type 2 Diabetes treatment on All-Cause Morta…
RT @i_petersen: Gosh my HbA1c is too high! We investigated the impact of being eligible for Type 2 Diabetes treatment on All-Cause Morta…
Really interesting study on diagnostic cutoffs in diabetes! Great work!
RT @i_petersen: Gosh my HbA1c is too high! We investigated the impact of being eligible for Type 2 Diabetes treatment on All-Cause Morta…
RT @i_petersen: Gosh my HbA1c is too high! We investigated the impact of being eligible for Type 2 Diabetes treatment on All-Cause Morta…
Gosh my HbA1c is too high! We investigated the impact of being eligible for Type 2 Diabetes treatment on All-Cause Mortality | CLEP @DovePress https://t.co/WzTLiEacP9 Great team work @dceaarhus @UCL_PCPH @dr_rwt @gianlubaio @lapdce73 @manujsharma10 h